This recent Wall Street Journal article is about the FDA’s approval of the Eli Lilly radiotracer florbetapir, known by the brand name Amyvid. This chemical tracer can now be used in PET scans to detect amyloid protein, which is present if Alzheimer’s and a few other disorders are in the brain. There is no insurance coverage for this type of PET scan because there is currently no treatment available to someone if the diagnosis is Alzheimer’s.
Here’s a link to the article:
online.wsj.com/article/
HEALTH INDUSTRY
Alzheimer Diagnosis Possible With Scan
Wall Street Journal
By Shirley S. Wang
Updated April 9, 2012, 12:24 a.m. ET
On that same webpage is a video of the author talking about the scan.